Influence of Erbanxiao solution on inhibiting angiogenesis in stasis toxin stagnation of non-small cell lung cancer

$8.00
VAT Exempt
In stock
SKU
JTCM-499

To read the full abstract subscribe to the JCM online archive

In this study 60 lung cancer patients were randomly assigned to either a treatment group, who were given the Chinese herbal medicine Erbanxiao, and a control group, who received ...
More Information
Author Liu Junbao et al.
JCM Issue JCM103
Write Your Own Review
You're reviewing:Influence of Erbanxiao solution on inhibiting angiogenesis in stasis toxin stagnation of non-small cell lung cancer

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.